Plantar Fasciitis in Runners Statistics 2026
Plantar Fasciitis in Runners Statistics 2026
Plantar fasciitis affects between 10% and 22% of runners, making it one of the most common foot injuries in the sport. In the general population, it occurs in about 10% of adults, but running populations show prevalence rates up to twice as high. The condition accounts for approximately 10% of all running-related injuries and 11-15% of all foot symptoms requiring professional care. Around 90% of cases resolve within 12 months with conservative treatment, but the first-morning heel pain that defines the condition can persist for months before improvement begins. These 16 statistics map the full picture of plantar fasciitis in runners.
Plantar fasciitis is the inflammation and degeneration of the thick band of tissue connecting the heel bone to the toes. For runners, it is a particularly frustrating injury because it typically worsens with the first steps after rest - meaning morning heel pain is often the clearest symptom - and responds slowly to standard treatments. Understanding the epidemiology helps set realistic recovery expectations and identify who is most at risk.
This post covers 16 verifiable statistics on plantar fasciitis prevalence, demographics, risk factors, treatment outcomes, and economic impact in runners.
1. Plantar fasciitis affects up to 22% of runners
Plantar fasciitis prevalence among runners reaches as high as 22% in some literature, compared to approximately 10% in the general population. Studies show considerable variation in reported rates (2.7% to 17.5%) depending on the population studied and the injury definition used, with some reports citing up to 22% when including subclinical presentations. This wide range reflects differences between recreational and competitive runners, road and trail populations, and varying diagnostic criteria used across studies.
Source: LER Magazine - The Epidemiology of Plantar Fasciitis
2. Plantar fasciitis accounts for 10% of all running-related injuries
Systematic reviews of running injuries consistently place plantar fasciitis at approximately 10% of all running-related injuries by specific diagnosis. StatPearls (NIH Bookshelf) confirms this figure, noting that plantar fasciitis accounts for about 10% of runner-related injuries and 11-15% of all foot symptoms requiring professional medical attention. This makes it one of the top five most common running injuries alongside patellofemoral pain, Achilles tendinopathy, IT band syndrome, and medial tibial stress syndrome.
Source: NIH StatPearls - Plantar Fasciitis
3. About 10% of the general population develops plantar fasciitis
Beyond the running population, plantar fasciitis occurs in approximately 10% of adults across the lifespan. With 83% of cases affecting active working adults aged 25-65, it is not exclusively a runner's problem but a condition strongly associated with sustained weight-bearing activity. The dual exposure of running stress plus occupational standing time substantially elevates risk compared to either alone.
Source: NIH StatPearls - Plantar Fasciitis
4. Women show higher plantar fasciitis prevalence than men, especially aged 45-64
A PMC analysis of US adult data found a higher prevalence of plantar fasciitis in women compared to men, particularly in the 45-64 age group. Those with a body mass index above 25 kg/m2 also showed elevated rates. The age-related increase in women may relate to declining estrogen levels affecting plantar fascial tissue elasticity and the transition away from more supportive footwear across the lifespan. These demographics highlight that plantar fasciitis is not exclusively a high-mileage athlete problem.
Source: PMC - Prevalence and Pharmaceutical Treatment of Plantar Fasciitis in United States Adults
5. 90% of plantar fasciitis cases resolve within 12 months with conservative treatment
Systematic reviews consistently report that approximately 90% of plantar fasciitis cases resolve with conservative treatment within 12 months. This is one of the most important statistics for runners facing this diagnosis: the prognosis is good, but the timeline is long. Most patients see significant improvement within 6-12 months using a combination of stretching, footwear modification, orthotics, and activity modification. The problem is that the first 2-3 months often show frustratingly slow progress.
6. Over two-thirds of plantar fasciitis patients use OTC products for pain management
A US population study on plantar fasciitis pharmacological treatment found that more than two-thirds of patients used over-the-counter products for pain management. NSAIDs were the most common OTC choice (49.48% of patients), followed by acetaminophen (26.93%). This high rate of self-management reflects both the accessibility of first-line treatments and the prolonged nature of the condition, which many patients manage for months without formal medical consultation.
Source: PMC - Prevalence and Pharmaceutical Treatment of Plantar Fasciitis in United States Adults
7. NSAIDs accounted for 58.7% of the plantar fasciitis treatment market in 2024
Grand View Research's analysis of the global plantar fasciitis treatment market found that the NSAIDs segment held the largest revenue share at 58.7% in 2024. This confirms that anti-inflammatory pharmacological management remains the dominant first-line approach in clinical practice. The finding aligns with clinical guidelines recommending short-term NSAID use as part of a broader conservative management protocol, typically alongside physical therapy and orthotics.
Source: Grand View Research - Plantar Fasciitis Treatment Market Size and Share Report
8. The global plantar fasciitis treatment market was worth $1.28 billion in 2024
The plantar fasciitis treatment market was estimated at USD 1.28 billion in 2024, projected to reach USD 3.45 billion by 2033 at an 11.9% compound annual growth rate. This market size reflects both the prevalence of the condition and the growing range of treatment options including custom orthotics, extracorporeal shockwave therapy (ESWT), platelet-rich plasma (PRP) injections, and advanced physical therapy protocols. Rising running participation globally is a driver of this market growth.
Source: Grand View Research - Plantar Fasciitis Treatment Market Size and Share Report
9. PRP injections provide superior pain relief over corticosteroids in head-to-head research
A study published in the American Journal of Physical Medicine and Rehabilitation compared platelet-rich plasma (PRP) versus corticosteroid injections for plantar fasciitis. PRP provided superior pain relief and improved foot function over corticosteroid injections, particularly at 6-month and 12-month follow-up points. However, corticosteroids provided faster short-term relief in the first 4-6 weeks. For runners seeking to return to training quickly, this trade-off between short-term vs. long-term outcomes is clinically significant.
Source: Grand View Research - Plantar Fasciitis Treatment Market Report citing AJPMR data
10. Extracorporeal shockwave therapy is recommended as an evidence-based second-line treatment
Systematic reviews on plantar fasciitis treatment have reached general consensus that extracorporeal shockwave therapy (ESWT) is an effective mode of therapy, particularly for chronic cases that do not respond to initial conservative treatment. ESWT stimulates healing in degenerative plantar fascia tissue and is now considered a standard second-line option when 3-6 months of stretching, orthotics, and activity modification have not produced adequate improvement.
Source: PMC - A Systematic Review of Systematic Reviews on Plantar Fasciitis
11. A 2025 PMC study identified running distance as a biomechanical risk factor for plantar fasciitis
Research published in PMC in early 2025 examined running distance and biomechanical factors as risk contributors for plantar fasciitis. The study confirmed that increased running distance, particularly rapid increases in weekly mileage, elevates stress on the plantar fascia. Biomechanical factors including excessive foot pronation and reduced ankle dorsiflexion range of motion independently increase plantar fascia loading during the push-off phase of running gait.
Source: PMC - Running Distance and Biomechanical Risk Factors for Plantar Fasciitis
12. Plantar fasciitis is more common in runners aged 40-60 than younger runners
Clinical data consistently shows that plantar fasciitis peaks in the 40-60 age range among recreational runners. This pattern reflects age-related changes in plantar fascial tissue elasticity and the cumulative loading effects of years of running. Younger runners are not immune - plantar fasciitis does occur in runners in their 20s and 30s - but the incidence curve rises sharply with age, particularly in runners who maintain high training volumes into middle age without adequate soft-tissue recovery work.
Source: LER Magazine - The Epidemiology of Plantar Fasciitis
13. First-morning heel pain is the hallmark symptom, present in over 80% of cases
Clinical literature on plantar fasciitis diagnosis consistently identifies first-step pain after periods of rest - most notably the first steps in the morning - as the defining symptom present in over 80% of diagnosed cases. The pain typically eases after 5-10 minutes of walking as the fascia warms and loosens, then worsens again with prolonged activity. This pain pattern distinguishes plantar fasciitis from other causes of heel pain including heel fat pad syndrome and posterior tibial tendinopathy.
Source: NIH StatPearls - Plantar Fasciitis
14. Plantar fasciitis incidence in a Dutch primary care cohort was 10.5 per 1,000 person-years
A retrospective cohort study using Dutch primary care data published in PMC found plantar heel pain incidence of 10.5 per 1,000 person-years in the general adult population. Among those who sought care, the majority received conservative management. The study also found that approximately 25% of patients with plantar heel pain had persistent symptoms at one year, consistent with the 90% resolution rate leaving roughly 10% with chronic or recurrent presentations.
Source: PMC - Incidence, Prevalence, and Management of Plantar Heel Pain in Dutch Primary Care
15. Calf and plantar fascia stretching programs have strong evidence for reducing pain
Multiple systematic reviews confirm that stretching protocols targeting the plantar fascia and calf musculature are effective first-line treatments, with the best-supported regimen being the plantar fascia-specific stretch (pulling the toes into dorsiflexion). A PMC review of plantar fasciitis current concepts identified stretching as one of the two most consistently effective conservative treatments alongside orthotic support. For runners, these stretches can be performed before the first steps of the day to reduce morning pain severity.
Source: PMC - Plantar Fasciitis: An Updated Review
16. Plantar fasciitis accounts for 1 million physician visits annually in the United States
US epidemiological data places plantar fasciitis-related physician visits at approximately 1 million per year, making it one of the most common outpatient foot complaints. The high visit volume translates to substantial healthcare expenditure and lost training time across the running population. Given that the condition disproportionately affects recreational runners in their 40s and 50s - the core demographic of the US road racing population - its economic and training impact is concentrated in the most active running cohort.
Source: NIH StatPearls - Plantar Fasciitis
What These Numbers Tell Runners
Plantar fasciitis is overwhelmingly a condition of gradual onset and slow resolution. The 90% recovery rate within 12 months is reassuring, but the path to that recovery rarely runs straight. Most runners who develop plantar fasciitis will manage it for 3-6 months before seeing consistent improvement, and a meaningful minority (10-25%) experience chronic or recurrent symptoms.
The risk factor data points directly at what to address: rapid mileage increases, insufficient ankle dorsiflexion, and excessive foot pronation are the three most modifiable biomechanical contributors. As shown in our broader running injury by body part analysis, the foot and ankle complex accounts for 26% of all running injuries, and plantar fasciitis is the primary driver of that burden.
The treatment market data tells a secondary story: runners are spending significantly on this condition, with a $1.28 billion global market that is projected to nearly triple by 2033. That growth reflects both rising participation rates and the high recurrence risk that keeps patients returning for multiple rounds of treatment. The broader context from our running injury statistics overview confirms plantar fasciitis as one of the five most costly running injuries in terms of time off training.
For most runners, plantar fasciitis is manageable - but it requires patience, consistent stretching, and a willingness to modify training load during recovery.
Keep Moving While You Heal
Managing plantar fasciitis means adjusting your training, not stopping entirely. Cross-training runs on lower-impact surfaces, reducing mileage gradually, and logging every session to track load accumulation are all part of smart management.
Runify syncs from Apple Watch, Garmin, or Strava so every run you can do - shorter, slower, or modified - still earns XP and keeps your rank active. Your leaderboard position across 800m through the marathon reflects your current effort, not your injury history.
Ready to make your runs count? Download Runify on the App Store and turn every mile into XP across leaderboards from 800m through the marathon.
4.8 stars on the App Store, 626+ reviews worldwide.
Download Runify on the App Store
4.8 on the App Store · Built for iOS